Literature DB >> 25762707

Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology.

Masayuki Nakao1, Rira Hoshi2, Yuichi Ishikawa3, Yosuke Matsuura4, Hirofumi Uehara4, Mingyon Mun4, Ken Nakagawa4, Sakae Okumura4.   

Abstract

OBJECTIVES: Positive pleural lavage cytology (PLC) is considered as a precursor condition of pleural dissemination (PD) or malignant pleural effusion (PE), and one of the poor prognostic factors in surgically resected non-small-cell lung cancer (NSCLC) patients. Although PD and PE are classified as M1a, PLC does not contribute to the tumour, node and metastasis (TNM) classification of the Union Internationale Contre le Cancer. This study aimed to evaluate the prognostic effect of positive PLC status in surgically resected NSCLC patients compared with PD and/or PE. We also aimed to consider the contribution of positive PLC status to the TNM classification.
METHODS: We reviewed 1572 consecutive patients with completely resected NSCLC, and analysed the relationship between PLC status, other clinicopathological factors and prognosis. The survival rates of 45 patients with PD and/or PE were also investigated.
RESULTS: Positive preresection PLC (pre-PLC) status was observed in 56 patients. Pre-PLC status was significantly associated with other clinicopathological factors. Positive pre-PLC patients exhibited a worse 5-year overall survival (50.6%) compared with negative pre-PLC patients (78.0%), but better survival than PD and/or PE patients (21.0%). Prognosis of positive pre-PLC patients was equal to that of pT3, negative pre-PLC patients; survival equality was observed when patients were stratified according to pN0, pN1 and pN2.
CONCLUSIONS: Positive pre-PLC had the significant prognostic effect in surgically resected NSCLC patients. However, it is not a contraindication for surgical resection, unlike PD and/or PE. Our data suggest that positive pre-PLC should be classified as pT3 in next TNM classification.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Lung cancer; Pleural dissemination; Pleural effusion; Surgery

Mesh:

Year:  2015        PMID: 25762707     DOI: 10.1093/icvts/ivv047

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

1.  Comparison of the clinical benefits for non-small cell lung cancer patients between different volume of pleural lavage fluid following video-assisted thoracoscopic lobectomy and systematic mediastinal lymph node dissection: study protocol for a randomized controlled trial.

Authors:  Jian Zhou; Chengwu Liu; Shulei Man; Mengyuan Lyu; Hu Liao; Nan Chen; Yuhui Cheng; Lunxu Liu
Journal:  Trials       Date:  2020-02-27       Impact factor: 2.279

2.  Prognostic Value of Pleural Lavage Cytology in Patients with Lung Cancer Resection: An Updated Meta-Analysis.

Authors:  Chun-Mei Wang; Zhou-Gui Ling; Yan-Bin Wu; Shuang-Qi Cai; Zhen-Ming Tang; Cong Wu; Yi-Qiang Chen
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

Review 3.  [Latest Progress of Intraoperative Pleural Lavage Cytology in Lung Cancer Surgery].

Authors:  Donglai Chen; Ranran Fu; Pingfan Shi; Shuang Qin; Chang Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-09-20

4.  Clinicopathological significance of microRNA-21 in extracellular vesicles of pleural lavage fluid of lung adenocarcinoma and its functions inducing the mesothelial to mesenchymal transition.

Authors:  Shiori Watabe; Yoshinao Kikuchi; Shigeki Morita; Daisuke Komura; Satoe Numakura; Arisa Kumagai-Togashi; Masato Watanabe; Noriyuki Matsutani; Masafumi Kawamura; Masanori Yasuda; Hiroshi Uozaki
Journal:  Cancer Med       Date:  2020-02-24       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.